Research Topics
| Ron EpelbaumSummaryCountry: Israel Publications
| Collaborators
|
Detail Information
Publications
Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CTRon Epelbaum
Department of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
J Nucl Med 54:12-8. 2013..This study aimed to assess the role of a quantitative dynamic PET model in pancreatic cancer as a potential index of tumor aggressiveness and predictor of survival...
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network studyWendy Jeanneret-Sozzi
Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon, CH 1011 Lausanne, Switzerland
BMC Cancer 8:86. 2008..To asses the clinical profile, treatment outcome and prognostic factors in primary breast lymphoma (PBL)...
Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancerRon Epelbaum
Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
J Surg Oncol 81:138-43. 2002..Therefore, a phase II study was conducted to evaluate the efficacy of gemcitabine combined with radiation therapy in patients with localized unresectable adenocarcinoma of the pancreas...
Curcumin and gemcitabine in patients with advanced pancreatic cancerRon Epelbaum
Department of Oncology, Rambam Health Care Campus, Haifa, Israel
Nutr Cancer 62:1137-41. 2010..Further studies should be conducted to evaluate the ability of other formulations of curcumin to enhance the effect of chemotherapy in cancer patients...
A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preservedEldad J Dann
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
Am J Hematol 87:32-6. 2012..Six cycles of tailored BEACOPP, for patients with adverse prognostic factors, provide encouraging long-term PFS and OS, and fertility is preserved in most females...
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J Dann
Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel
Blood 109:905-9. 2007..02). Early interim fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG)-PET/CT is a useful tool for adjustment of chemotherapy on an individual basis. Similar EFS and OS rates were observed for patients in both risk groups...
Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatmentOra Israel
Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel
J Nucl Med 43:1295-303. 2002..The purpose of the present study was to evaluate the role of 67Ga scintigraphy and CT in treatment monitoring of bone lymphoma...
(18)F-FDG avidity in lymphoma readdressed: a study of 766 patientsMichal Weiler-Sagie
Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel
J Nucl Med 51:25-30. 2010..The aim of the present study is to enlarge the growing body of evidence concerning (18)F-FDG avidity of lymphoma to provide a basis for future guidelines...
FDG avidity and PET/CT patterns in primary gastric lymphomaLea Radan
Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel
Eur J Nucl Med Mol Imaging 35:1424-30. 2008..This study assesses FDG avidity and PET/CT patterns in newly diagnosed PGL...
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphomaZeev Blumenfeld
Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
Fertil Steril 89:166-73. 2008..To minimize the gonadotoxic effect of chemotherapy by the cotreatment with a GnRH agonistic analogue (GnRH-a)...
Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?Ora Israel
Department of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel
J Nucl Med 45:2045-51. 2004....
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphomaEldad J Dann
Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Bruce Rapaport Faculty of Medicine, Technion, Haifa, Israel 31096
Hum Reprod 20:2247-9. 2005..4 mg/m2 (maximum 2 mg) and prednisone 100 mg/day were given every 3 weeks)...
Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 yearsReuven Bergman
Department of Dermatology, Rambam Medical Center, Haifa, Israel
Int J Dermatol 41:735-43. 2002..The aim of our study was to evaluate the applicability and significance of the new classification systems to the diagnosis and management of non-mycosis fungoides (non-MF) PCL...
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphomaEldad J Dann
Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Technion, P O Box 9602, Haifa 31096, Israel
Haematologica 95:1198-206. 2010..Historically, the assessment was based on a static all-or-none scoring system. However, the clinical significance of any positivity in interim FDG-PET/CT has not been defined...
Excellent long-term survival in patients with early-stage primary bone lymphoma treated with doxorubicin-based chemotherapy and local radiotherapyMoshe Efraim Stein
Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
Am J Clin Oncol 25:603-5. 2002..The exact rule of radiation therapy is yet to be determined...
Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphomaOra Israel
Department of Nuclear Medicine, Rambam Medical Center and the B Rappaport Faculty of Medicine, Israel Institute of Technology, Technion, Haifa, Israel
Cancer 94:873-8. 2002..Ga-67 scintigraphy during treatment is an early indicator of treatment-related features of lymphoma cells. The ability of risk factors and Ga-67 to predict disease outcome was compared in 139 patients with aggressive NHL...
Art therapy improved depression and influenced fatigue levels in cancer patients on chemotherapyGil Bar-Sela
Division of Oncology, Rambam Health Care Campus, Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
Psychooncology 16:980-4. 2007..The purpose of this study was to determine whether improvement in depression, anxiety or fatigue during chemotherapy following anthroposophy art therapy intervention is substantial enough to warrant a controlled trial...
Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative studyRachel Bar-Shalom
Department of Nuclear Medicine, Rambam Medical Center and the Technion, Israel Institute of Technology, Bat Galim, Haifa 35254, Israel
Radiology 227:353-60. 2003..CONCLUSION: In this selected group of patients with lymphoma, camera-based FDG PET allowed a significantly more accurate definition of active disease compared with that allowed with 67Ga scintigraphy...
Primary spinal epidural lymphoma: patients' profile, outcome, and prognostic factors: a multicenter Rare Cancer Network studyVirginie Monnard
Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Int J Radiat Oncol Biol Phys 65:817-23. 2006..After therapy, local control is excellent and systemic relapse occurs in less than half the cases. Combined modality treatment appears to be superior to RT alone...
